Journal
SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY
Volume 1, Issue -, Pages -Publisher
BMC
DOI: 10.1186/1747-597X-1-15
Keywords
-
Categories
Funding
- NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016090, R01DA007601, P50DA016094, R01DA013814] Funding Source: NIH RePORTER
- NIDA NIH HHS [DA13814, R01 DA016090, DA 16090, P50 DA016094, DA07601, R01 DA013814, DA16094] Funding Source: Medline
Ask authors/readers for more resources
Background: Non-medical/illegal use of prescription stimulants popularly have been referred to as study drugs. This paper discusses the current prevalence and consequences of misuse of these drugs and implications of this information for drug policy. Results: Study drugs are being misused annually by approximately 4% of older teens and emerging adults. Yet, there are numerous consequences of misuse of prescription stimulants including addiction, negative reactions to high dosages, and medical complications. Policy implications include continuing to limit access to study drugs, finding more safe prescription drug alternatives, interdiction, and public education. Conclusion: Much more work is needed on prescription stimulant misuse assessment, identifying the extent of the social and economic costs of misuse, monitoring and reducing access, and developing prevention and cessation education efforts.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available